(Q54592700)

1 June 2018

title

Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. (English)

1 reference

1 June 2018

1 reference

8

1 reference

1 June 2018

author name string

Jazmin Pérez-Rojas

1

1 reference

1 June 2018

Jorge A Blanco

2

1 reference

1 June 2018

Cristino Cruz

3

1 reference

1 June 2018

Joyce Trujillo

4

1 reference

1 June 2018

Vishal S Vaidya

5

1 reference

1 June 2018

Norma Uribe

6

1 reference

1 June 2018

Joseph V Bonventre

7

1 reference

1 June 2018

Norma A Bobadilla

9

1 reference

1 June 2018

publication date

11 July 2006

1 reference

1 June 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

1 June 2018

volume

292

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

F131-9

1 reference

1 June 2018

Regression of existing glomerulosclerosis by inhibition of aldosterone

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Role of aldosterone in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Aldosterone in the development and progression of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Effect of aldosterone on renal transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

A role for mineralocorticoid receptor blockade in the prevention of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Aldosterone target organ protection by eplerenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Protective effect of spironolactone on endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00147.2006

10.1152/AJPRENAL.00147.2006

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

16835406

1 reference

1 June 2018